주식/증권 ➡️ 중립

NRx targets 2026 KETAFREE approval and outlines SPARC-TMS trial in 400 patients backed by military funding

Seeking Alpha - Market News 08/18/2026 03:03:03 PM 23회

원문 기사 보기

관련 뉴스

Average U.S. pump prices during Trump's term now exceed Biden's

Want $1,000 a Month in Passive Income? Start With This Brilliant Dividend ETF.

5 Best High Growth Stocks Outside Big Tech

5 Best Biotech Stocks Under $10 to Buy

뉴스 목록으로